A new trading day began on Tuesday, with Guardant Health Inc (NASDAQ: GH) stock price up 10.27% from the previous day of trading, before settling in for the closing price of $101.87. GH’s price has ranged from $33.75 to $112.43 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -33.61% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 13.36%. With a float of $124.56 million, this company’s outstanding shares have now reached $125.01 million.
Guardant Health Inc (GH) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Guardant Health Inc is 3.72%, while institutional ownership is 96.58%. The most recent insider transaction that took place on Dec 17 ’25, was worth 11,769. In this transaction Director of this company sold 116 shares at a rate of $101.46, taking the stock ownership to the 7,993 shares. Before that another transaction happened on Dec 15 ’25, when Company’s Co-Chief Executive Officer sold 90,565 for $103.82, making the entire transaction worth $9,402,220. This insider now owns 2,047,143 shares in total.
Guardant Health Inc (GH) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.62 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.36% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.86% during the next five years compared to -33.61% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Here are Guardant Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.21, a number that is poised to hit -0.77 in the next quarter and is forecasted to reach -2.71 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Let’s dig in a bit further. During the last 5-days, its volume was 2.1 million. That was inferior than the volume of 2.83 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 74.68%.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 99.81%, which indicates a significant increase from 99.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.82 in the past 14 days, which was higher than the 3.59 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $98.72, while its 200-day Moving Average is $63.04. However, in the short run, Guardant Health Inc’s stock first resistance to watch stands at $115.87. Second resistance stands at $119.42. The third major resistance level sits at $126.39. If the price goes on to break the first support level at $105.35, it is likely to go to the next support level at $98.38. The third support level lies at $94.83 if the price breaches the second support level.
Guardant Health Inc (NASDAQ: GH) Key Stats
With a market capitalization of 14.53 billion, the company has a total of 126,041K Shares Outstanding. Currently, annual sales are 739,020 K while annual income is -436,370 K. The company’s previous quarter sales were 265,200 K while its latest quarter income was -92,730 K.
